Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005.

    Tyndall A, Walker UA, Cope A, Dazzi F, De Bari C, Fibbe W, Guiducci S, Jones S, Jorgensen C, Le Blanc K, Luyten F, McGonagle D, Martin I, Bocelli-Tyndall C, Pennesi G, Pistoia V, Pitzalis C, Uccelli A, Wulffraat N, Feldmann M.

    Arthritis Res Ther. 2007;9(1):301. Review.

    PMID:
    17284303
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.

    Zhao S, Wehner R, Bornhäuser M, Wassmuth R, Bachmann M, Schmitz M.

    Stem Cells Dev. 2010 May;19(5):607-14. Review.

    PMID:
    19824807
    [PubMed - indexed for MEDLINE]
    3.

    Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

    Djouad F, Bouffi C, Ghannam S, Noël D, Jorgensen C.

    Nat Rev Rheumatol. 2009 Jul;5(7):392-9. Review.

    PMID:
    19568253
    [PubMed - indexed for MEDLINE]
    4.

    Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.

    Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L, Martini A.

    Stem Cells. 2008 Feb;26(2):562-9.

    PMID:
    18024418
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Mesenchymal stromal cells.

    Keating A.

    Curr Opin Hematol. 2006 Nov;13(6):419-25. Review.

    PMID:
    17053453
    [PubMed - indexed for MEDLINE]
    6.

    [Mesenchymal stem cells and the immune system--immunosuppression without drugs?].

    Kiss J, Urbán VS, Dudics V, Vas V, Uher F.

    Orv Hetil. 2008 Feb 24;149(8):339-46. Review. Hungarian.

    PMID:
    18281229
    [PubMed - indexed for MEDLINE]
    7.

    Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.

    McTaggart SJ, Atkinson K.

    Nephrology (Carlton). 2007 Feb;12(1):44-52. Review.

    PMID:
    17295660
    [PubMed - indexed for MEDLINE]
    8.

    Immunomodulatory properties of mesenchymal stromal cells.

    Nauta AJ, Fibbe WE.

    Blood. 2007 Nov 15;110(10):3499-506. Epub 2007 Jul 30. Review.

    PMID:
    17664353
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].

    Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D.

    Rev Med Interne. 2009 Mar;30(3):287-99. Epub 2008 Oct 17. Review. French.

    PMID:
    18930338
    [PubMed - indexed for MEDLINE]
    10.

    Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.

    Chen PM, Yen ML, Liu KJ, Sytwu HK, Yen BL.

    J Biomed Sci. 2011 Jul 18;18:49. Review.

    PMID:
    21762539
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.

    Tyndall A, Uccelli A.

    Bone Marrow Transplant. 2009 Jun;43(11):821-8. Epub 2009 Mar 23. Review.

    PMID:
    19308035
    [PubMed - indexed for MEDLINE]
    12.

    Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.

    Nasef A, Ashammakhi N, Fouillard L.

    Regen Med. 2008 Jul;3(4):531-46. Review.

    PMID:
    18588475
    [PubMed - indexed for MEDLINE]
    13.

    Mesenchymal stromal cells.

    Bernardo ME, Locatelli F, Fibbe WE.

    Ann N Y Acad Sci. 2009 Sep;1176:101-17. Review.

    PMID:
    19796238
    [PubMed - indexed for MEDLINE]
    14.

    Potential of mesenchymal stem cell therapy.

    Dazzi F, Horwood NJ.

    Curr Opin Oncol. 2007 Nov;19(6):650-5. Review.

    PMID:
    17906466
    [PubMed - indexed for MEDLINE]
    15.

    Multipotent mesenchymal stromal cells and immune tolerance.

    Noël D, Djouad F, Bouffi C, Mrugala D, Jorgensen C.

    Leuk Lymphoma. 2007 Jul;48(7):1283-9. Review.

    PMID:
    17613755
    [PubMed - indexed for MEDLINE]
    16.

    Immunosuppression by mesenchymal stromal cells: from culture to clinic.

    Jones BJ, McTaggart SJ.

    Exp Hematol. 2008 Jun;36(6):733-41. Review.

    PMID:
    18474304
    [PubMed - indexed for MEDLINE]
    17.

    Potential of mesenchymal stem cells for the therapy of autoimmune diseases.

    Pistoia V, Raffaghello L.

    Expert Rev Clin Immunol. 2010 Mar;6(2):211-8. Review.

    PMID:
    20402384
    [PubMed - indexed for MEDLINE]
    18.

    Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

    Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D.

    Arch Neurol. 2008 Jun;65(6):753-61.

    PMID:
    18541795
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.

    Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, Dominici M, Greil J, Handgretinger R.

    Blood Cells Mol Dis. 2008 Jan-Feb;40(1):25-32. Epub 2007 Sep 14.

    PMID:
    17869550
    [PubMed - indexed for MEDLINE]
    20.

    Treatment of graft-versus-host-disease with mesenchymal stromal cells.

    Kebriaei P, Robinson S.

    Cytotherapy. 2011 Mar;13(3):262-8. Epub 2011 Jan 13. Review.

    PMID:
    21231805
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk